Cold-EEZE Cold Remedy UltraMELT Chews NDC 71179-350

NDC codes

FDA NDC Directory

Product NDC (as listed)71179-350Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71179-0350Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
71179-350-24	71179035024	2 BLISTER PACK in 1 BOX (71179-350-24) / 12 TABLET, CHEWABLE in 1 BLISTER PACKMarketed from Jul 1, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cold-EEZE Cold Remedy UltraMELT ChewsSuffix: UltraMELT Chews
Generic name (nonproprietary): zinc gluconate
Active ingredients: Zinc gluconate — 13.3 mg/1
Dosage form: Tablet, Chewable
Route: Oral
Labeler: Vespyr Brands LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 1, 2021
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Copper Ion Absorption (Physiologic effect)
Identifiers: Product ID 71179-350_514358e2-3cb7-5306-e063-6294a90a59bbSPL ID 514358e2-3cb7-5306-e063-6294a90a59bbSPL set ID 04b6992d-c7c5-56c7-e063-6394a90ae8d0UNII U6WSN5SQ1Z
Pharmacologic class: Copper Absorption Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471179035024 followed by a unit qualifier and the quantity

Package 71179-0350-24. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 1, 2026.

Indications (excerpt from the label)

Uses reduces the duration of the common cold reduces the severity of cold symptoms: cough, sore throat, nasal congestion, post nasal drip and/or hoarseness

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)